Fusion Biopsy

Prostate MRI combined with fusion biopsy has become an important tool in the screening, evaluation, diagnosis, targeted biopsy, surveillance and focal therapy of the prostate cancer

BiopSee^® brings these modalities together by overlaying diagnostic MRI images onto real-time ultrasound. This fusion allows clinicians to precisely target suspicious lesions identified on MRI and biopsy them under ultrasound guidance. The strength of MRI’s soft tissue resolution is combined with the immediacy of ultrasound visualization, giving doctors a clearer path to accurate sampling.

Once MRI and ultrasound images are co-registered, the biopsy needle can be guided directly to the areas of concern. Published clinical studies have reported detection rates using BiopSee^® fusion biopsy ranging up to 86%–100% for targeted mpMRI-suspicious lesions.²

^{-------------------------------------------------------}

² Hadaschik BA, Kuru TH, Tulea C, Rieker P, Popeneciu IV, Simpfendörfer T, et al. A Novel Stereotactic Prostate Biopsy System Integrating Pre-Interventional Magnetic Resonance Imaging and Live Ultrasound Fusion. Journal of Urology [Internet]. 2011 Dec 1 [cited 2025 Dec 8];186(6):2214–20. Available from: https://doi.org/10.1016/j.juro.2011.07.102